Trade

Fuel Feud Finale? Kobre & Kim Seeks $1.2 Billion in Damages, Higher Interest Against Philips 66 for Trade Secret Misuse

by

OAKLAND, Calif. — A recent court proceedings have escalated as Kobre & Kim LLP, a law firm representing Propel Fuels, filed a motion in the Alameda County Superior Court to enhance a jury verdict against energy company Phillips 66. The law firm is seeking to increase the damages awarded to Propel Fuels to $1.2 billion and is asking for the application of a 10% interest rate on post-judgment amounts. The legal dispute centers on allegations that Phillips 66 misused proprietary information from Propel Fuels, a company that specializes in renewable fuels. Two months prior, a … Read more

Chief Judge Mark A. Barnett Takes Center Stage at U.S. Court of International Trade: Navigating the Future of Global Commerce

by

Chief Judge Mark A. Barnett, who presides over the U.S. Court of International Trade, recently issued a decision that once again underscores the complexity and significance of international trade regulations. This ruling delves into the nuances of global commerce laws, influencing businesses and governments worldwide. Barnett’s leadership in the court signifies a pivotal role in interpreting and enforcing laws that govern the United States’ trade relationships. His decisions have the potential to affect markets, industries, and international diplomatic relations, highlighting the importance of the Court of International Trade in global economic governance. The U.S. Court … Read more

Insulet Wins Massive $452 Million in Trade Secret Lawsuit Against EOFlow Over Insulin Device Innovations

by

BOSTON — In a landmark legal decision, Insulet Corp., headquartered in Massachusetts, triumphed in a major trade secrets lawsuit against South Korea-based EOFlow Co. Ltd., with a federal jury awarding the U.S. medical device maker a colossal $452 million. The verdict, reached on Tuesday, marks a significant moment in the realm of intellectual property rights within the highly competitive medical device industry. Insulet Corp. has been developing its innovative OmniPod insulin pump since the early 2000s, a device that has significantly impacted the management of diabetes through its advanced, wearable technology. The lawsuit emerged following … Read more

Insulet Wins $452 Million in Landmark Trade Secrets Lawsuit Against Eoflow

by

In a significant legal victory, Insulet Corp. was awarded $452 million in damages after a federal jury found that Eoflow Co., a South Korean medical device company, engaged in trade secret misappropriation. The verdict came after a closely watched trial that highlighted the fierce competition in the medical device sector, particularly in technologies related to diabetes management. The lawsuit, initiated by Insulet, accused Eoflow of illegally acquiring and using Insulet’s proprietary information to develop and market its own competing product. The core of the dispute centered around technology for wearable insulin pumps, which are crucial … Read more